Printer Friendly

Browse Bladder cancer topic

Development and progression subtopic

Articles

1-65 out of 65 article(s)
Title Author Type Date Words
GeneCentric Therapeutics Enters into Research Collaboration with Janssen on Genomic Drug Response Biomarkers for Non-Muscle Invasive Bladder Cancer. Aug 12, 2020 343
Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts. Jalloh, Mohamed; Cassell, Ayun; Diallo, Thierno; Gaye, Omar; Ndoye, Medina; Mbodji, Mouhamadou M.; M Jun 30, 2020 4691
Emerging intravesical therapies for the management of bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward. Chehroudi, All Cyrus; Black, Peter C. Jun 1, 2020 7930
The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA. Shen, Chengquan; Liu, Jing; Wang, Jirong; Yang, Xiaokun; Niu, Haitao; Wang, Yonghua Report May 31, 2020 3732
Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer. Zhang, Zhao; Chen, Dongshan; Li, Zeyan; Liu, Zhao; Yan, Lei; Xu, Zhonghua Mar 31, 2020 5484
Evaluation of Current Status of Urine and Serum Biomarkers in the Diagnosis and Follow-up of Bladder Cancer: Review. Yildizhan, Mehmet; Gemalmaz, Hakan Dec 1, 2019 7133
Exploring the Pathological Mechanism of Bladder Cancer Based on Tumor Mutational Burden Analysis. Ma, Yao; Feng, Xiao-Fei; Yang, Wan-Xia; You, Chong-Ge Sep 30, 2019 4523
Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors Before Treatment for Metastatic Bladder Cancer Patients Receiving First-Line Chemotherapy. Bozkurt, Oktay; Dogan, Ender; Firat, Sedat Tank; Cosar, Ramazan; Inanc, Mevlude; Zararsiz, Gozde Ert Sep 1, 2019 4561
Bladder Cancer in the Genomic Era. Guo, Charles C.; Czerniak, Bogdan Jun 1, 2019 7356
Can High Preoperative Neutrophil-lymphocyte Ratio Predict the Recurrence and Progression Risk of Non-muscle-invasive Bladder Tumors? Kizilay, Fuat; Simsir, Adnan Jun 1, 2019 4663
Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guerin for Bladder Cancer. Liu, Yuqing; Lu, Jian; Huang, Yi; Ma, Lulin Mar 31, 2019 8805
Intravesical Therapies in Non-muscle Invasive Bladder Tumors. Geyik, Serdar Report Mar 1, 2019 5128
Predicting Lamina Propria Invasion in Patients with Non-muscle-invasive Bladder Cancer: Do RDW and NLR Really Work? Senturk, Aykut Bugra; Ekici, Musa; Aydin, Cemil; Baykam, Mehmet Murat; Tas, Tuncay; Arda, Ersan; Cak Report Mar 1, 2019 3009
Vascular Endothelial Growth Factor and Thrombospondin-1 mRNA Expression in Bladder Tumors: Correlation with Histopathology and Prognosis. Ozveren, Bora; Turkeri, Levent Report Mar 1, 2019 3728
Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience. Rayn, Kareem N.; Hale, Graham R.; Bloom, Jonathan B.; Gold, Samuel A.; Carvalho, Filipe L.F.; Mehral Sep 1, 2018 2998
Recurrence and upstaging rates of T1 high-grade urothelial carcinoma of the bladder on repeat resection in a Canadian, resource-limited, healthcare system. Kinnaird, Adam; Dromparis, Peter; Evans, Howard Report Aug 1, 2018 1931
NICE approves Roche's Tecentriq as therapy for pre-treated bladder cancer. May 18, 2018 163
NICE approves Roche's Tecentriq as therapy for pre-treated bladder cancer. May 18, 2018 167
Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non-muscle-invasive bladder cancer: Patients' and urologic oncologists' perspectives. Sayyid, Rashid K.; Sayyid, Abdallah K.; Klaassen, Zachary; Hersey, Karen; Goldberg, Hanan; Perlis, N Report May 1, 2018 4872
Clinical Results of Intravesical Application of BCG and Interferon-[alpha] 2A for Superficial Bladder Tumor Prophylaxis. Hazar, Aydin Ismet; Arat, Can; Ceylan, Osman; Calisir, Vedat Apr 1, 2018 2531
Adipose Tissue-Secreted Factors Alter Bladder Cancer Cell Migration. Hariharan, Nisha; Ashcraft, Keith A.; Svatek, Robert S.; Livi, Carolina B.; Wilson, Desiree; Kaushik Jan 1, 2018 6634
Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer/Mesane Kanseri icin Immunoterapotik Potansiyele Sahip Mycobacterium Brumae Ekstresi Fraksiyonlari. Ertork, Zeliha; Buber, Esra; Ozen, Haluk; Celikbicak, Omor; Salih, Bekir; Acan, N. Leyla Report Sep 1, 2017 4527
The Effect of Sex and Age Differences on Pathology Results in Primary Bladder Cancer Patients/Primer Mesane Kanseri Tanisi Alan Hastalarin Cinsiyet ve Yas Farkliliginin Patolojik Sonuclara Etkisi. Tork, Hakan; Un, Sitki; Ergani, Batuhan Report Sep 1, 2017 3303
The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder. Arslankoz, Sehbal; Kulac, Ibrahim; Baydar, Dilek Ertoy Report Sep 1, 2017 2577
Simple test predicts return of bladder cancer. Brief article Aug 1, 2017 201
Kas Ynvaz Mesane Kanserinde Risk Adaptif Neoadjuvan Kemoterapi/Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer. Atag, Elif; Karaoglu, Aziz; Kucuk, Omer Report Jun 1, 2017 4884
Pathology review impacts clinical management of patients with T1-T2 bladder cancer. Traboulsi, Samer L.; Brimo, Fadi; Yang, Yutong; Maedler, Chelsea; Prevost, Noemie; Tanguay, Simon; A Report Jun 1, 2017 4582
High-grade urothelial carcinoma of bladder transforming to micropapillary variant on follow-up. Kumari, Nitu; Jha, Anupama; Vasudeva, Pawan; Agrawal, Usha Clinical report May 1, 2017 1872
Bavarian Nordic signs collaboration agreement with Roche to evaluate CV301 and Tecentriq in bladder cancer. Mar 13, 2017 340
Bavarian Nordic signs collaboration agreement with Roche to evaluate CV301 and Tecentriq in bladder cancer. Mar 13, 2017 336
Bavarian Nordic announces Roche collaboration to assess CV301 and Tecentriq in bladder cancer. Mar 10, 2017 248
Bavarian Nordic announces Roche collaboration to assess CV301 and Tecentriq in bladder cancer. Mar 10, 2017 244
Epigenetik Degisiklikler ve Mesane Kanseri Arasindaki Iliski/The Relationship between Bladder Cancer and Epigenetic Alterations. Ozen, Ata; Ulgen, Ali; Can, Cavit Report Mar 1, 2017 4430
Deciphering the Roles of Thiazolidinediones and PPAR[gamma] in Bladder Cancer. Chiu, Melody; McBeth, Lucien; Sindhwani, Puneet; Hinds, Terry D. Report Jan 1, 2017 7920
Network biomarkers of bladder cancer based on a genome-wide genetic and epigenetic network derived from next-generation sequencing data. Li, Cheng-Wei; Chen, Bor-Sen Report Jan 1, 2016 9861
Molecular biomarkers in bladder cancer: novel potential indicators of prognosis and treatment outcomes. Nagata, Masayoshi; Muto, Satoru; Horie, Shigeo Report Jan 1, 2016 4089
Systemic inflammatory response based on neutrophil-to-lymphocyte ratio as a prognostic marker in bladder cancer. Kim, Hyung Suk; Ku, Ja Hyeon Report Jan 1, 2016 8416
Clinical Experiences of Korean Medicine Treatment against Urinary Bladder Cancer in General Practice. Park, Taeyeol; Lee, Sanghun Disease/Disorder overview Jan 1, 2016 4967
Muscle invasive bladder cancer culminating with leptomeningeal carcinomatosis. Swallow, Tom W.; Mabbutt, Scott; Bell, Charles R.W. Report Nov 1, 2015 1066
Caffeine Suppresses Apoptosis of Bladder Cancer RT4 Cells in Response to Ionizing Radiation by Inhibiting Ataxia Telangiectasia Mutated-Chk2-p53 Axis. Zhang, Zhe-Wei; Xiao, Jing; Luo, Wei; Wang, Bo-Han; Chen, Ji-Min Report Nov 1, 2015 4302
Urothelial bladder cancer in young adults: diagnosis, treatment and clinical behaviour. Gunlusoy, Bulent; Ceylan, Yasin; Degirmenci, Tansu; Kozacioglu, Zafer; Yonguc, Tarik; Bozkurt, Halil Report Oct 1, 2015 2828
CUA guidelines on the management of non-muscle invasive bladder cancer. Kassouf, Wassim; Traboulsi, Samer L.; Kulkarni, Girish S.; Breau, Rodney H.; Zlotta, Alexandre; Fair Report Oct 1, 2015 14446
Metastatic signet-ring cell carcinoma of the urinary bladder: a novel management approach to a rare tumour. Pugashetti, Neil; Yap, Stanley A.; Lara, Primo N., Jr.; Gandour-Edwards, Regina; Dall'Era, Marc A. Case study Apr 1, 2015 1838
Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer. Ozyalvacli, Mehmet Emin; Ozyalvacli, Gulzade; Kocaaslan, Ramazan; Cecen, Kursat; Uyeturk, Ugur; Kema Report Mar 1, 2015 4155
Re: Factors affecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG. Dec 31, 2014 399
Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells. Wang, W.; Zhu, H.; Zhang, H.; Zhang, L.; Ding, Q.; Jiang, H. Report Dec 1, 2014 3509
Tumour stage on re-staging transurethral resection predicts recurrence and progression-free survival of patients with high-risk non-muscle invasive bladder cancer. Bishr, Mohamed; Lattouf, Jean-Baptiste; Latour, Mathieu; Saad, Fred Report May 1, 2014 2981
Synchronous primary malignancies of the male urogenital tract. Qarro, Abdelmounaim; Ammani, Abdelghani; Bazine, Khalil; Najoui, Mohammed; Samir, Jamaleddine; Alami Report May 1, 2014 2380
Source of most cases of invasive bladder cancer identified. Apr 21, 2014 404
Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer. Todenhofer, Tilman; Hennenlotter, Jorg; Esser, Michael; Mohrhardt, Sarah; Aufderklamm, Stefan; Bottg Report Jan 1, 2014 5053
Metastasis to sartorius muscle from a muscle invasive bladder cancer. Katafigiotis, Ioannis; Athanasiou, Antonios; Levis, Panagiotis K.; Fragkiadis, Evangelos; Sfoungaris Case study Jan 1, 2014 1583
Hsp74, a potential bladder cancer marker, has direct interaction with keratin 1. Chen, Ling; Wang, YaRong; Zhao, Le; Chen, Wei; Dong, Chunhui; Zhao, Xinhan; Li, Xu Report Jan 1, 2014 3542
Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green. Inoue, Shogo; Shiina, Hiroaki; Mitsui, Yozo; Yasumoto, Hiroaki; Matsubara, Akio; Igawa, Mikio Report May 1, 2013 3475
A case of isolated rectal recurrence of muscle invasive bladder cancer. Kassam, Shaqil N.; Aziz, Zared; Hung, Lick San; Sridhar, Srikala S. Clinical report May 1, 2013 2942
Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort. Power, Nicholas E.; Kassouf, Wassim; Bell, David; Aprikian, Armen G.; Fradet, Yves; Lacombe, Louis; Report Dec 1, 2012 3981
A smoking cessation program as a resource for bladder cancer patients. Vilensky, Daniel; Lawrentschuk, Nathan; Hersey, Karen; Fleshner, Neil E. Report Oct 1, 2012 4348
Chemoprevention in bladder cancer: What's new? Lattouf, Jean-Baptiste Disease/Disorder overview Dec 1, 2009 3741
The optimal management of T1 high-grade bladder cancer. Nepple, Kenneth G.; O'Donnell, Michael A. Disease/Disorder overview Dec 1, 2009 4950
The management of BCG failure in non-muscle-invasive bladder cancer: an update. Zlotta, Alexandre R.; Fleshner, Neil E.; Jewett, Michael A. Report Dec 1, 2009 6161
Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat. Ehdaie, Behfar; Smith, Steven C.; Theodorescu, Dan Report Dec 1, 2009 4391
NMP22: Does it have a predictive potential for recurrence and progression in non-muscle-invasive bladder cancer? Kassouf, Wassim Clinical report Dec 1, 2009 724
Mogoltacin enhances vicristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Rassouli, Behnam F.; Matin, M.M.; Iranshahi, M.; Bahrami, A.R.; Neshati, V.; Mollazadeh, S.; Neshati Report Mar 1, 2009 4743
Urinary Tract Conditions; Overview. Clinical report Aug 3, 2007 5640
Cytokeratin 7 and Cytokeratin 20 in Primary Urinary Bladder Carcinoma and Matched Lymph Node Metastasis. Jiang, Jiazhong; Ulbright, Thomas M.; Younger, Cheryl; Sanchez, Katya; Bostwick, David G.; Koch, Mic Jul 1, 2001 2034
Current concepts in biomarker technology for bladder cancers. Burchardt, Martin; Burchardt, Tatjana; Shabsigh, Ahmad; De La Taille, Alexandre; Benson, Mitchell C. May 1, 2000 9478

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters